Statistics for Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy

Total visits

views
Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy 3

Total visits per month

views
April 2024 0
May 2024 0
June 2024 1
July 2024 0
August 2024 0
September 2024 0
October 2024 0

File Visits

views
MUS-66-50.pdf 19

Top country views

views
United States 3

Top city views

views
Indianapolis 3